Rigel Pharmaceuticals (RIGL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Rigel Pharmaceuticals-Aktie (RIGL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	90.66% 101.69	53.33	57.60	55.31	36.84
Cost Of Revenue	2.15% 4.504	4.409	5.789	8.026	2.807
Gross Profit	98.64% 97.18	48.92	51.81	47.28	34.03
Operating Expenses	0.20% 36.08	36.15	35.15	33.23	33.59
Interest Income/Expense	1.13% 1.874	1.853	1.955	2.06	2.029
Benefits Costs and Expenses	0.28% 41.70	41.82	42.37	41.25	36.39
Costs And Expenses	0.05% 40.58	40.56	40.94	41.25	36.39
Operating Income/Loss	378.38% 61.10	12.77	16.66	14.06	0.447
Income/Loss From Continuing Operations Before Tax	421.08% 59.98	11.51	15.22	14.06	-1.03
Income Tax Expense/Benefit	467.69% 0.369	0.065	-	-	-
Income/Loss From Continuing Operations After Tax	420.82% 59.61	11.45	14.34	12.42	-1.03
Net Income/Loss	420.82% 59.61	11.45	14.34	12.42	-1.03
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.43% 17.89	17.81	0.023	17.60	17.55
Diluted Average Shares	0.04% 18.16	18.17	0.088	17.65	17.55
Basic Earnings Per Share	420.31% 3.33	0.64	0.81	0.71	-0.06
Diluted Earnings Per Share	420.63% 3.28	0.63	0.81	0.70	-0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%